Table 3.
Subjects improving the minimal clinically important difference in IIEF-EF score at 3 and 12 months after PUL in combined L.I.F.T. and MedLift cohorts (both LL and OML subjects)
| 3 Months | 12 Months | |||||
|---|---|---|---|---|---|---|
| IIEF-EF Baseline Severity | n/N | Increase Mean±SD | Increase Range | n/N | Increase Mean±SD | Increase Range |
| Severe (1–10) | 1/19 | 8.0 | 8–8 | 2/21 | 17.0 ± 5.7 | 13–21 |
| Moderate (11–16) | 12/23 | 10.1 ± 1.6 | 8–13 | 8/21 | 8.8 ± 3.2 | 5–15 |
| Mild (17–25) | 22/36 | 5.8 ± 2.3 | 2–10 | 21/35 | 5.3 ± 2.4 | 2–10 |
| Total Improved (%) | 35/78 (45%) | 31/77 (40%) | ||||
IIEF-EF International Index of Erectile Function erectile function domain, MCID minimal clinically important difference (at least 2 point increase for mild ED, 5 for moderate ED, and 7 for severe ED)